A shortened regime for the treatment of vulvovaginal candidosis with a new presentation of miconazole.
A new presentation of miconazole, in the form of soft gelatin capsules for intravaginal use, gave considerable therapeutic success in the treatment of vulvovaginal candidosis. Mycological cure rates greater than 85% and clinical cure rates greater than 90% were achieved by treatment with 7 miconazole capsules, regardless of whether these were used daily for 7 days or twice daily for 3 1/2 days. The new formulation seems to possess the dual advantage of ease of application and shorter duration of treatment.
D000293:Adolescent; D000328:Adult; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D002214:Capsules; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D008825:Miconazole / Q000008:administration & dosage* / Q000627:therapeutic use; D008875:Middle Aged; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy
D002214:Capsules; D007093:Imidazoles; D008825:Miconazole